Lydus Medical

Lydus Medical is a medical technology company based in Ra’anana, Israel, focused on automated microvascular anastomosis devices for small blood and lymph vessels. Founded in 2017 as a spin-off from Mor Research Applications, the company has quickly progressed from concept to commercial product. The flagship product, Vesseal™, is an automated suture deployment system that simplifies the microsurgical vessel coupling process. It allows for the precise placement of eight microsutures, enhancing speed and accuracy while reducing ischemic time and operating room duration. Vesseal™ is applicable in various clinical fields, including breast reconstruction, organ transplants, and vascular access for hemodialysis. The device has received FDA 510(k) clearance and is available in the United States through select distributors. Lydus Medical holds a strong patent portfolio and has garnered investments from notable entities, including Sanara Ventures and the Israel Innovation Authority. The company aims to enhance microsurgery by automating complex procedures, improving surgical outcomes across multiple applications.

• Employees 8
• Founded 2017
• Total Funding $2700000